Brain ventricles, CSF and cognition: a narrative review

Psychogeriatrics. 2022 Jul;22(4):544-552. doi: 10.1111/psyg.12839. Epub 2022 Apr 30.

Abstract

The brain ventricles are structures that have been related to cognition since antiquity. They are essential components in the development and maintenance of brain functions. The aging process runs with the enlargement of ventricles and is related to a less selective blood-cerebrospinal fluid barrier and then a more toxic cerebrospinal fluid environment. The study of brain ventricles as a biological marker of aging is promissing because they are structures easily identified in neuroimaging studies, present good inter-rater reliability, and measures of them can identify brain atrophy earlier than cortical structures. The ventricular system also plays roles in the development of dementia, since dysfunction in the clearance of beta-amyloid protein is a key mechanism in sporadic Alzheimer's disease. The morphometric and volumetric studies of the brain ventricles can help to distinguish between healthy elderly and persons with mild cognitive impairment (MCI) and dementia. Brain ventricle data may contribute to the appropriate allocation of individuals in groups at higher risk for MCI-dementia progression in clinical trials and to measuring therapeutic responses in these studies, as well as providing differential diagnosis, such as normal pressure hydrocephalus. Here, we reviewed the pathophysiology of healthy aging and cognitive decline, focusing on the role of the choroid plexus and brain ventricles in this process.

Keywords: Alzheimer's disease; aging; cerebral ventricles; choroid plexus; cognitive impairment; pathophysiology.

Publication types

  • Review

MeSH terms

  • Aged
  • Alzheimer Disease* / psychology
  • Amyloid beta-Peptides / metabolism
  • Biomarkers / cerebrospinal fluid
  • Brain / diagnostic imaging
  • Brain / metabolism
  • Cognition
  • Cognitive Dysfunction* / diagnosis
  • Cognitive Dysfunction* / psychology
  • Disease Progression
  • Humans
  • Reproducibility of Results

Substances

  • Amyloid beta-Peptides
  • Biomarkers